Besivance and Keratosis - actinic (solar) - a phase IV clinical study of FDA data


Keratosis - actinic (solar) is reported only by a few people who take Besivance.

The phase IV clinical study analyzes which people take Besivance and have Keratosis - actinic (solar). It is created by eHealthMe based on reports of 995 people who have side effects while taking Besivance from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2022

995 people reported to have side effects when taking Besivance.
Among them, 3 people (0.3%) have Keratosis - actinic (solar).

What is Besivance?

Besivance has active ingredients of besifloxacin hydrochloride. eHealthMe is studying from 1,000 Besivance users for its effectiveness, alternative drugs and more.

What is Keratosis - actinic (solar)?

Keratosis - actinic (solar) (a small, rough spot occurring on skin that has been chronically exposed to the sun) is found to be associated with 1,368 drugs and 827 conditions by eHealthMe.

Number of Besivance and Keratosis - actinic (solar) reports submitted per year:

Could Besivance cause Keratosis - actinic (solar)?

Gender of people who have Keratosis - actinic (solar) when taking Besivance *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Keratosis - actinic (solar) when taking Besivance *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Besivance *:

  1. Singulair: 3 people, 100.00%
  2. Novolog: 3 people, 100.00%
  3. Levemir: 3 people, 100.00%
  4. Januvia: 3 people, 100.00%
  5. Basaglar: 3 people, 100.00%
  6. Actonel: 3 people, 100.00%

Common side effects people have besides Keratosis - actinic (solar) *:

  1. Wound: 3 people, 100.00%
  2. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 3 people, 100.00%
  3. Skin Haemorrhage (bleeding into skin): 3 people, 100.00%
  4. Skin Graft Failure (skin transplant failed): 3 people, 100.00%
  5. Skin Cancer: 3 people, 100.00%
  6. Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 3 people, 100.00%
  7. Scar: 3 people, 100.00%
  8. Rash Pruritic (redness with itching): 3 people, 100.00%
  9. Rash Erythematous (redness of the skin): 3 people, 100.00%
  10. Neoplasm Skin (skin tumour): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Besivance and have Keratosis - actinic (solar)?

Check whether Keratosis - actinic (solar) is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Keratosis - actinic (solar) and when was it recovered:

Expand to all the drugs that have ingredients of besifloxacin hydrochloride:

Alternative drugs to, pros and cons of Besivance:

Common Besivance side effects:

Browse all side effects of Besivance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Keratosis - actinic (solar) treatments and more:

COVID vaccines that are related to Keratosis - actinic (solar):

Common drugs associated with Keratosis - actinic (solar):

All the drugs that are associated with Keratosis - actinic (solar):

Common conditions associated with Keratosis - actinic (solar):

All the conditions that are associated with Keratosis - actinic (solar):

How the study uses the data?

The study uses data from the FDA. It is based on besifloxacin hydrochloride (the active ingredients of Besivance) and Besivance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: